| Year |
Citation |
Score |
| 2022 |
Ross AG, Chaqour B, McDougald DS, Dine KE, Duong TT, Shindler RE, Yue J, Liu T, Shindler KS. Selective Upregulation of SIRT1 Expression in Retinal Ganglion Cells by AAV-Mediated Gene Delivery Increases Neuronal Cell Survival and Alleviates Axon Demyelination Associated with Optic Neuritis. Biomolecules. 12. PMID 35740955 DOI: 10.3390/biom12060830 |
0.712 |
|
| 2021 |
Argyriou C, Polosa A, Song JY, Omri S, Steele B, Cécyre B, McDougald DS, Di Pietro E, Bouchard JF, Bennett J, Hacia JG, Lachapelle P, Braverman NE. AAV-mediated gene augmentation improves visual function in the PEX1-Gly844Asp mouse model for mild Zellweger spectrum disorder. Molecular Therapy. Methods & Clinical Development. 23: 225-240. PMID 34703844 DOI: 10.1016/j.omtm.2021.09.002 |
0.685 |
|
| 2021 |
Ross AG, McDougald DS, Khan RS, Duong TT, Dine KE, Aravand P, Bennett J, Chavali VRM, Shindler KS. Rescue of retinal ganglion cells in optic nerve injury using cell-selective AAV mediated delivery of SIRT1. Gene Therapy. PMID 33589779 DOI: 10.1038/s41434-021-00219-z |
0.739 |
|
| 2020 |
Chavali VRM, Haider N, Rathi S, Vrathasha V, Alapati T, He J, Gill K, Nikonov R, Duong TT, McDougald DS, Nikonov S, O'Brien J, Mills JA. Dual SMAD inhibition and Wnt inhibition enable efficient and reproducible differentiations of induced pluripotent stem cells into retinal ganglion cells. Scientific Reports. 10: 11828. PMID 32678240 DOI: 10.1038/s41598-020-68811-8 |
0.717 |
|
| 2019 |
McDougald DS, Papp TE, Zezulin AU, Zhou S, Bennett J. AKT3 Gene Transfer Promotes Anabolic Reprogramming and Photoreceptor Neuroprotection in a Pre-clinical Model of Retinitis Pigmentosa. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31043342 DOI: 10.1016/J.Ymthe.2019.04.009 |
0.605 |
|
| 2019 |
McDougald DS, Duong TT, Palozola KC, Marsh A, Papp TE, Mills JA, Zhou S, Bennett J. CRISPR Activation Enhances Potency of AAV Vectors Driven by Tissue-Specific Promoters. Molecular Therapy. Methods & Clinical Development. 13: 380-389. PMID 31024980 DOI: 10.1016/J.Omtm.2019.03.004 |
0.601 |
|
| 2019 |
Isgrig K, McDougald DS, Zhu J, Wang HJ, Bennett J, Chien WW. AAV2.7m8 is a powerful viral vector for inner ear gene therapy. Nature Communications. 10: 427. PMID 30683875 DOI: 10.1038/S41467-018-08243-1 |
0.534 |
|
| 2018 |
Dooley SJ, McDougald DS, Fisher KJ, Bennicelli JL, Mitchell LG, Bennett J. Spliceosome-Mediated Pre-mRNA trans-Splicing Can Repair CEP290 mRNA. Molecular Therapy. Nucleic Acids. 12: 294-308. PMID 30195768 DOI: 10.1016/J.Omtn.2018.05.014 |
0.642 |
|
| 2018 |
McDougald DS, Dine KE, Zezulin AU, Bennett J, Shindler KS. SIRT1 and NRF2 Gene Transfer Mediate Distinct Neuroprotective Effects Upon Retinal Ganglion Cell Survival and Function in Experimental Optic Neuritis. Investigative Ophthalmology & Visual Science. 59: 1212-1220. PMID 29494741 DOI: 10.1167/Iovs.17-22972 |
0.607 |
|
| 2016 |
McDougald DS, Kmiec E, Mills JA. Personalized models reveal mechanistic and therapeutic insights into CEP290-associated Leber congenital amaurosis. Stem Cell Investigation. 3: 65. PMID 27868047 DOI: 10.21037/sci.2016.10.03 |
0.479 |
|
| 2015 |
Chien WW, McDougald DS, Roy S, Fitzgerald TS, Cunningham LL. Cochlear gene transfer mediated by adeno-associated virus: Comparison of two surgical approaches. The Laryngoscope. PMID 25891801 DOI: 10.1002/Lary.25317 |
0.3 |
|
| 2015 |
Chien WW, Monzack EL, McDougald DS, Cunningham LL. Gene therapy for sensorineural hearing loss. Ear and Hearing. 36: 1-7. PMID 25166629 DOI: 10.1097/Aud.0000000000000088 |
0.313 |
|
| Show low-probability matches. |